Complicated Intra-Abdominal Infections: Developing Drugs for Treatment
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 1, 2018
May 7, 2020
d6add39a-f308-464b-a6b5-f0161eeea8a0
Related Documents
Anthrax: Developing Drugs for Prophylaxis of Inhalational Anthrax Guidance for Industry
Guidance DocumentMay 24, 2018Center for Drug Evaluation and Research
Migraine: Developing Drugs for Acute Treatment
Guidance DocumentFebruary 16, 2018Center for Drug Evaluation and Research
Complicated Urinary Tract Infections: Developing Drugs for Treatment
Guidance DocumentJune 1, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox